Hector R Martínez1, César E Escamilla-Ocañas2, Juan Miguel Tenorio-Pedraza3, David Gómez-Almaguer4, Jose Carlos Jaime-Perez4, Leticia A Olguín-Ramírez5, Sergio Salazar-Marioni2, María Teresa González-Garza3. 1. Instituto de Neurología y Neurocirugía, Centro Medico Zambrano Hellion, Tecnológico de Monterrey, Mexico; Servicio de Neurología, Hospital Universitario UANL, Mexico. Electronic address: dr.hectormartinez@medicos.tecsalud.mx. 2. Instituto de Neurología y Neurocirugía, Centro Medico Zambrano Hellion, Tecnológico de Monterrey, Mexico. 3. Terapia Celular, CITES, Escuela Nacional de Medicina, Tecnológico de Monterrey, Mexico. 4. Servicio de Hematología, Hospital Universitario UANL, Mexico. 5. Instituto de Neurología y Neurocirugía, Centro Medico Zambrano Hellion, Tecnológico de Monterrey, Mexico; Servicio de Neurología, Hospital Universitario UANL, Mexico.
Abstract
INTRODUCTION: Increased cytokine expression is a prominent finding in amyotrophic lateral sclerosis (ALS). Due to their interdependence and pleiotropism, interpretation of CSF concentrations of a single cytokine is challenging. We describe a cytokine analysis in ALS patients using a pathway-based statistical method to identify changes in the whole cytokine network. METHODS: We analyzed 19 cytokines in CSF of ALS patients and controls. An equality of concentration matrices was conducted that allowed us to evaluate disturbances in the relationship of cytokines between controls and ALS patients with less and more than 12months of disease length. MANOVA assessed differences in cytokines and interdependence was compared by partial correlations among specific pairs of cytokines. RESULTS: Seventy-seven ALS patients and 13 control subjects were included. Significant differences were identified in the cytokine pathway between controls and ALS patients with less (p<0.0001) and more than 12months of disease length (p<0.0001), and between ALS patients with less than 12months and those with more than 12months (p=0.0058). In ALS patients with a shorter disease length, IL4 and IL6 were negatively correlated (-0.3571), whereas in ALS>12months, a positive correlation was detected (0.4080). CONCLUSIONS: The pathway-based statistical method revealed remarkable variations in the whole cytokine pathway in ALS patients and controls. Cytokine-network changes and the positive correlation between IL4 and IL6 were related to disease length; these variations might explain the deleterious immunological effects on motor neurons. A further analysis using this method is needed to confirm the exact interaction among cytokines in ALS.
INTRODUCTION: Increased cytokine expression is a prominent finding in amyotrophic lateral sclerosis (ALS). Due to their interdependence and pleiotropism, interpretation of CSF concentrations of a single cytokine is challenging. We describe a cytokine analysis in ALSpatients using a pathway-based statistical method to identify changes in the whole cytokine network. METHODS: We analyzed 19 cytokines in CSF of ALSpatients and controls. An equality of concentration matrices was conducted that allowed us to evaluate disturbances in the relationship of cytokines between controls and ALSpatients with less and more than 12months of disease length. MANOVA assessed differences in cytokines and interdependence was compared by partial correlations among specific pairs of cytokines. RESULTS: Seventy-seven ALSpatients and 13 control subjects were included. Significant differences were identified in the cytokine pathway between controls and ALSpatients with less (p<0.0001) and more than 12months of disease length (p<0.0001), and between ALSpatients with less than 12months and those with more than 12months (p=0.0058). In ALSpatients with a shorter disease length, IL4 and IL6 were negatively correlated (-0.3571), whereas in ALS>12months, a positive correlation was detected (0.4080). CONCLUSIONS: The pathway-based statistical method revealed remarkable variations in the whole cytokine pathway in ALSpatients and controls. Cytokine-network changes and the positive correlation between IL4 and IL6 were related to disease length; these variations might explain the deleterious immunological effects on motor neurons. A further analysis using this method is needed to confirm the exact interaction among cytokines in ALS.
Authors: Krista J Spiller; Clark R Restrepo; Tahiyana Khan; Myrna A Dominique; Terry C Fang; Rebecca G Canter; Christopher J Roberts; Kelly R Miller; Richard M Ransohoff; John Q Trojanowski; Virginia M-Y Lee Journal: Nat Neurosci Date: 2018-02-20 Impact factor: 24.884
Authors: Maria Teresa Gonzalez-Garza; Hector Ramon Martinez; Delia E Cruz-Vega; Martin Hernandez-Torre; Jorge E Moreno-Cuevas Journal: Dis Markers Date: 2018-10-10 Impact factor: 3.434
Authors: Rosanna Tortelli; Chiara Zecca; Marco Piccininni; Sara Benmahamed; Maria Teresa Dell'Abate; Maria Rosaria Barulli; Rosa Capozzo; Petronilla Battista; Giancarlo Logroscino Journal: Front Neurol Date: 2020-11-13 Impact factor: 4.003
Authors: Robert D Henderson; Jan M Agosti; Pamela A McCombe; Kathryn Thorpe; Susan Heggie; Saman Heshmat; Mark W Appleby; Brian W Ziegelaar; David T Crowe; Garry L Redlich Journal: Medicine (Baltimore) Date: 2021-10-22 Impact factor: 1.817